XTIDE 40MG

Xtide 40mg capsule contains enzalutamide, the active ingredient, which is classified as an androgen receptor inhibitor. This medication is prescribed for men diagnosed with prostate cancer. It is particularly effective for those with elevated testosterone levels, especially when previous treatments such as hormonal therapy or testosterone-reducing surgery have failed to completely eliminate the cancer. Additionally, it is appropriate for metastatic cases where the cancer has spread beyond the prostate and responds to hormone therapy or testosterone-lowering surgery. Xtide is also indicated for non-metastatic prostate cancer that is sensitive to castration (surgical removal of the testicles) but has a significant risk of metastasis and biochemical recurrence.

Taking Xtide 40mg capsule is not advisable if you have allergies to the active ingredients or any other components of this medication. It is also not suitable for children and adolescents under 18 years of age. Men are strongly encouraged to employ effective contraceptive measures during treatment and for three months following therapy, as the drug may pose risks to a developing fetus. If you are pregnant or planning to conceive, consult your doctor about suitable contraceptive options. Monitoring of bone density is also recommended throughout the treatment.

Prior to starting treatment, it is essential to inform your healthcare provider about any existing infections or issues related to your kidneys, heart, or liver. Patients with ischemic heart disease should be closely monitored for potential risk factors. If you experience a seizure, worsening headache, disorientation, blindness, or any other visual disturbances, contact your doctor immediately. It is crucial to disclose all medications, including over-the-counter drugs, vitamins, and herbal supplements, to your physician before beginning therapy.